Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Wikman, Harriet ^a   Sielaff Frimpong, Bettina ^a   Kropidlowski, Jolanthe ^a   Witzel, Isabell ^a   Milde Langosch, Karin ^a   Sauter, Guido ^a   Westphal, Manfred ^a   Lamszus, Katrin ^a   Pantel, Klaus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR;

ADULT; AGE; ALLELIC IMBALANCE; ARTICLE; BONE MARROW; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER BRAIN METASTASIS; CANCER GRADING; CANCER PATIENT; CHROMOSOMAL LOCALIZATION; CHROMOSOME 11P; CHROMOSOME 11P15; CHROMOSOME DELETION; CHROMOSOME LOSS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCUS; GENE SILENCING; GENE TARGETING; GENETIC MARKER; HISTOLOGY; HUMAN; HUMAN TISSUE; IFITM2 GENE; LSP1 GENE; LYMPH NODE; MAJOR CLINICAL STUDY; MENOPAUSE; NUCLEOTIDE SEQUENCE; PRIMARY TUMOR; PRKCDBP GENE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPON1 GENE; TRIM34 GENE; TRIPLE NEGATIVE BREAST CANCER; TUMOR VOLUME;

ADULT; BRAIN NEOPLASMS; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; RECURRENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 84868286194     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047537     Document Type: Article

References (34)

1. Eichler AF, Chung E, Kodack DP, Loeffler JS, Fukumura D, et al. (2011) The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol 8: 344-356.
2. Leong SP, Cady B, Jablons DM, Garcia-Aguilar J, Reintgen D, et al. (2006) Clinical patterns of metastasis. Cancer Metastasis Rev 25: 221-232.
3. Bergamaschi A, Kim YH, Wang P, Sorlie T, Hernandez-Boussard T, et al. (2006) Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer 45: 1033-1040.
4. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541.
5. Nordgard SH, Johansen FE, Alnaes GI, Bucher E, Syvanen AC, et al. (2008) Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients. Genes Chromosomes Cancer 47: 680-696.
6. Nishizaki T, DeVries S, Chew K, Goodson WH III, Ljung BM, et al. (1997) Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 19: 267-272.
7. Petersen I, Hidalgo A, Petersen S, Schluns K, Schewe C, et al. (2000) Chromosomal imbalances in brain metastases of solid tumors. Brain Pathol 10: 395-401.
8. Hampl M, Hampl JA, Schwarz P, Frank S, Hahn M, et al. (1998) Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis. Invasion Metastasis 18: 81-95.
9. Wang C, Iakovlev VV, Wong V, Leung S, Warren K, et al. (2009) Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study. Genes Chromosomes Cancer 48: 1091-1101.
10. Wikman H, Lamszus K, Detels N, Uslar L, Wrage M, et al. (2012) Relevance of PTEN loss in brain metastasis formation of breast cancer patients. Breast Cancer Res 14: R49.
11. Rigaud G, Missiaglia E, Moore PS, Zamboni G, Falconi M, et al. (2001) High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res 61: 285-292.
12. Bepler G, Gautam A, McIntyre LM, Beck AF, Chervinsky DS, et al. (2002) Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer. J Clin Oncol 20: 1353-1360.
13. Fornari D, Steven K, Hansen AB, Jepsen JV, Poulsen AL, et al. (2006) Transitional cell bladder tumor: predicting recurrence and progression by analysis of microsatellite loss of heterozygosity in urine sediment and tumor tissue. Cancer Genet Cytogenet 167: 15-19.
14. Takita K, Sato T, Miyagi M, Watatani M, Akiyama F, et al. (1992) Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res 52: 3914-3917.
15. Chunder N, Mandal S, Roy A, Roychoudhury S, Panda CK, (2004) Analysis of different deleted regions in chromosome 11 and their interrelations in early- and late-onset breast tumors: association with cyclin D1 amplification and survival. Diagn Mol Pathol 13: 172-182.
16. Han W, Han MR, Kang JJ, Bae JY, Lee JH, et al. (2006) Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer. BMC Cancer 6: 92.
17. Dellas A, Torhorst J, Schultheiss E, Mihatsch MJ, Moch H, (2002) DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer. Clin Cancer Res 8: 1210-1216.
18. Karnik P, Paris M, Williams BR, Casey G, Crowe J, et al. (1998) Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis. Hum Mol Genet 7: 895-903.
19. Regitnig P, Moser R, Thalhammer M, Luschin-Ebengreuth G, Ploner F, et al. (2002) Microsatellite analysis of breast carcinoma and corresponding local recurrences. J Pathol 198: 190-197.
20. Wrage M, Ruosaari S, Eijk PP, Kaifi JT, Hollmen J, et al. (2009) Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion. Clin Cancer Res 15: 1566-1574.
21. Hannemann J, Meyer-Staeckling S, Kemming D, Alpers I, Joosse SA, et al. (2011) Quantitative high-resolution genomic analysis of single cancer cells. PLoS One 6: e26362.
22. Zochbauer-Muller S, Fong KM, Geradts J, Xu X, Seidl S, et al. (2005) Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation. Oncogene 24: 6249-6255.
23. Winqvist R, Hampton GM, Mannermaa A, Blanco G, Alavaikko M, et al. (1995) Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 55: 2660-2664.
24. Xu XL, Wu LC, Du F, Davis A, Peyton M, et al. (2001) Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res 61: 7943-7949.
25. Gaedcke J, Traub F, Milde S, Wilkens L, Stan A, et al. (2007) Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer. Mod Pathol 20: 864-870.
26. Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, et al. (2008) Subtypes of breast cancer show preferential site of relapse. Cancer Res 68: 3108-3114.
27. Peng S, Lu B, Ruan W, Zhu Y, Sheng H, et al. (2011) Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. Breast Cancer Res Treat 127: 309-324.
28. Fanale D, Amodeo V, Corsini LR, Rizzo S, Bazan V, et al. (2011) Breast cancer genome-wide association studies: there is strength in numbers. Oncogene.
29. Lee JH, Kang MJ, Han HY, Lee MG, Jeong SI, et al. (2011) Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNFalpha-induced apoptosis. Clin Cancer Res 17: 7551-7562.
30. Tong SY, Ki KD, Lee JM, Kang MJ, Ha TK, et al. (2010) Frequent inactivation of hSRBC in ovarian cancers by promoter CpG island hypermethylation. Acta Obstet Gynecol Scand 89: 629-635.
31. Lee JH, Byun DS, Lee MG, Ryu BK, Kang MJ, et al. (2008) Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses. Int J Cancer 122: 1573-1584.
32. McMahon KA, Zajicek H, Li WP, Peyton MJ, Minna JD, et al. (2009) SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function. EMBO J 28: 1001-1015.
33. Martinez R, Martin-Subero JI, Rohde V, Kirsch M, Alaminos M, et al. (2009) A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics 4: 255-264.
34. Caren H, Djos A, Nethander M, Sjoberg RM, Kogner P, et al. (2011) Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma. BMC Cancer 11: 66.